Ref (type) | Population | Outcome, Interventions | Results and statistical analysis | Effect size | Favours |
Adverse effects | |||||
[56]
RCT 3-armed trial |
94 people |
Adverse effects
with repifermin (at either dose) with placebo Absolute results not reported |
Reported as not significant The RCT may have lacked power to detect a clinically important difference between groups |
Not significant |